Colinz Laboratories logo

Colinz Laboratories

COLINZLABORATORIESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹9.10 Cr
Volatility
Moderate
P/E Ratio
3.3
EBITDA
₹0.90 Cr
Return on Equity
5.12%
Debt to Equity
0.04
Book Value
₹69.74
EPS
₹1.1
52W High
₹87.91
52W Low
₹36.11

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company is almost debt free.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -15.4%
  • The company has delivered a poor sales growth of -0.07% over past five years.
  • Company has a low return on equity of 5.41% over last 3 years.

Growth Rate

Revenue Growth
-2.94% higher than 3Y
Net Income Growth
0% lower than 3Y
Cash Flow Change
275% higher than 3Y
ROE
-2.29% lower than 3Y
ROCE
5.11% higher than 3Y
EBITDA Margin (Avg.)
15.92% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1.9
1.79
1.71
1.63
1.75
1.86
1.47
1.45
1.57
1.39
1.43
1.75
1.24
Expenses
1.74
1.67
1.57
1.51
1.59
1.69
1.4
1.35
1.44
1.31
1.33
1.66
1.18
Operating Profit
0.16
0.12
0.14
0.12
0.16
0.17
0.07
0.1
0.13
0.08
0.1
0.09
0.06
OPM %
8.42%
6.7%
8.19%
7.36%
9.14%
9.14%
4.76%
6.9%
8.28%
5.76%
6.99%
5.14%
4.84%
Other Income
0.04
0.08
0.05
0.11
0.07
0.08
0.08
0.08
0.08
0.16
0.08
0.17
2.89
Interest
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
Depreciation
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.04
0.04
0.04
0.04
0.04
PBT
0.16
0.16
0.15
0.19
0.19
0.21
0.11
0.13
0.16
0.19
0.13
0.21
2.9
Tax %
18.75%
25%
26.67%
31.58%
26.32%
23.81%
45.45%
-23.08%
25%
26.32%
30.77%
19.05%
17.24%
Net Profit
0.12
0.12
0.11
0.14
0.14
0.16
0.05
0.15
0.12
0.14
0.08
0.17
2.4
EPS in Rs
0.48
0.48
0.44
0.56
0.56
0.64
0.2
0.6
0.48
0.56
0.32
0.67
9.53
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7.88
8.1
8.05
7.83
7.59
7.53
6.16
6.97
7.15
7.03
6.53
6.14
5.81
Expenses
7.42
7.65
7.64
7.48
7.24
7.22
5.82
6.38
6.52
6.49
6.04
5.72
5.48
Operating Profit
0.46
0.45
0.41
0.35
0.35
0.31
0.34
0.59
0.63
0.54
0.49
0.42
0.33
OPM %
5.84%
5.56%
5.09%
4.47%
4.61%
4.12%
5.52%
8.46%
8.81%
7.68%
7.5%
6.84%
5.68%
Other Income
0.1
0.1
0.09
0.1
0.12
0.13
0.19
0.17
0.15
0.28
0.3
0.48
3.3
Interest
0.12
0.12
0.12
0.08
0.1
0.07
0.09
0.08
0.05
0.04
0.04
0.05
0.04
Depreciation
0.3
0.28
0.27
0.22
0.22
0.19
0.19
0.2
0.13
0.13
0.13
0.16
0.16
PBT
0.14
0.15
0.11
0.15
0.15
0.18
0.25
0.48
0.6
0.65
0.62
0.69
3.43
Tax %
35.71%
40%
-27.27%
-53.33%
26.67%
27.78%
16%
29.17%
23.33%
26.15%
20.97%
24.64%
—
Net Profit
0.1
0.09
0.14
0.23
0.12
0.13
0.21
0.34
0.46
0.49
0.5
0.51
2.79
EPS in Rs
0.22
0.2
0.31
0.5
0.26
0.28
0.46
0.74
1.83
1.95
1.98
2.02
11.08
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.54
3.54
3.54
3.54
3.54
3.54
3.55
3.55
2.52
2.52
2.52
2.52
Reserves
2.62
2.71
2.98
3.21
3.3
3.29
3.75
4.14
5.62
6.43
6.96
7.52
Borrowings
2.53
1.8
0.76
0.42
0.68
0.38
0.99
0.48
0.27
0.57
0.64
0.39
Other Liabilities
1.97
1.7
2.4
2.42
1.65
1.6
1.81
1.76
1.82
1.84
1.7
2.35
Total Liabilities
10.66
9.75
9.68
9.59
9.17
8.81
10.1
9.93
10.23
11.36
11.82
12.78
Fixed Assets
3.16
2.88
2.63
2.41
2.21
2.06
2.03
1.86
1.71
1.58
1.7
1.54
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.29
0.29
0.41
0.53
0.5
0.36
0.61
0.67
0.66
1.02
1.04
1.11
Other Assets
7.21
6.58
6.64
6.65
6.46
6.39
7.46
7.4
7.86
8.76
9.08
10.13
Total Assets
10.66
9.75
9.68
9.59
9.17
8.81
10.1
9.93
10.23
11.36
11.82
12.78
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.09
0.58
0.06
0.34
0.12
0.58
2.16
0.47
0.4
1.03
-1.45
2.54
Investing
0.03
0
-0.01
-0.11
-0.01
-0.04
-0.16
-0.03
0.01
0.01
-0.23
0.01
Financing
0.45
-0.73
-0.03
0.01
0.02
0.06
0.08
0.09
0.11
0.23
0.24
0.43
Net Cash Flow
0.57
-0.16
0.02
0.24
0.12
0.6
2.07
0.52
0.52
1.27
-1.45
2.98
Free Cash Flow
0.09
0.58
0.04
0.34
0.12
0.54
2
0.43
0.4
1.03
-1.71
2.54
CFO/OP
26
136
22
106
43
210
659
105
89
224
-253
650
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
62.53
60.83
66.65
78.31
80.79
72.22
77.03
63.36
57.69
44.65
36.89
49.93
Inventory Days
289
232
267
266
247
225
208
148
149
134
136
149
Days Payable
116
60.66
55.68
91.93
44.16
49.29
90
76.17
103
94.81
94.31
80.64
Cash Conversion Cycle
235
232
278
253
283
248
195
135
104
84.15
78.81
118
Working Capital Days
110
100
71.19
72.72
89.45
79.01
0
9.95
11.23
-22.84
73.22
-60.64
ROCE %
3.2%
3.23%
3%
3.18%
3.4%
3.39%
4.39%
6.8%
8.08%
7.7%
6.62%
7.2%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Colinz Laboratories insights

61 extracted metrics + investor summaries across FY08–FY26.

Log in — free

Shareholding Pattern

Promot.50.60%Others3.21%Public46.19%As ofJun 2026

Documents

Frequently Asked Questions about Colinz Laboratories

What does Colinz Laboratories Ltd do?
Incorporated in 1986, Colinz Laboratories is in the business of manufacturing and trading in pharmaceutical formulations[1]
Where is Colinz Laboratories Ltd (531210) listed?
Colinz Laboratories Ltd trades as COLINZLABORATORIESLTD on the NSE and under code 531210 on the BSE.
Which sector does Colinz Laboratories Ltd belong to?
Colinz Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Colinz Laboratories Ltd?
Colinz Laboratories Ltd has a market capitalisation of ₹9.1 Cr, which places it in the Small Cap band.
What is the PE ratio of Colinz Laboratories Ltd?
Colinz Laboratories Ltd trades at a PE ratio of 3.30, on earnings per share of ₹1.1, against a book value of ₹69.74 per share.
What is the 52-week high and low of Colinz Laboratories Ltd?
Over the last 52 weeks Colinz Laboratories Ltd has traded between ₹36.11 and ₹87.91.
What is the Return on Equity (ROE) of Colinz Laboratories Ltd?
Colinz Laboratories Ltd reported a return on equity of 5.12%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1986, Colinz Laboratories is in the business of manufacturing and trading in pharmaceutical formulations[1]

Website colinz.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531210.md for Colinz Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List